(Q31043570)

28 June 2017

title

Early diagnostic protein biomarkers for breast cancer: how far have we come? (English)

1 reference

28 June 2017

0 references

4

Jos H Beijnen

1 reference

28 June 2017

3

Petra H M Peeters

1 reference

28 June 2017

author name string

Annemieke W J Opstal-van Winden

series ordinal

1

1 reference

28 June 2017

Roel C H Vermeulen

series ordinal

2

1 reference

28 June 2017

Carla H van Gils

series ordinal

5

1 reference

28 June 2017

language of work or name

English

0 references

publication date

17 December 2011

1 reference

Breast Cancer Research and Treatment

28 June 2017

published in

1 reference

28 June 2017

volume

134

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

1-12

1 reference

How effective are breast cancer screening programmes by mammography? Review of the current evidence

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Clinical proteomics in breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

MALDI-TOF serum protein profiling for the detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Serum biomarkers to differentiate benign and malignant mammographic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Serum biomarkers for detection of breast cancers: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Detection and identification of potential biomarkers of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Identification of serum biomarkers for colon cancer by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Classification of cancer types by measuring variants of host response proteins using SELDI serum assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Breast cancer proteomics: a review for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Monitoring peptidase activities in complex proteomes by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Antibody arrays--an emerging tool in cancer proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Comparative analysis of proteome and transcriptome variation in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

Antibody Suspension Bead Arrays within Serum Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1907-2

10.1007/S10549-011-1907-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1001227084

0 references

1 reference